Document is current
Any future updates will be listed below
-
Authors
Kim, Soojin https://orcid.org/0000-0001-6519-1651
Wong, Yvette C. https://orcid.org/0000-0002-3188-4342
Gao, Fanding
Krainc, Dimitri https://orcid.org/0000-0002-4716-1886
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (F32 NS101778, K99 NS109252, R01 NS076054, R37NS096241)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
- License Information
-
More Information
Article History
Received: 4 May 2020
Accepted: 16 February 2021
First Online: 22 March 2021
Competing interests
: S.K., Y.C.W., and F.G. declare no competing interests. D.K. is a scientific advisor for Prevail Therapeutics and Intellia Therapeutics, as well as a venture partner at Orbimed.
